These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5697503)

  • 1. [On the urine acidity in patients with uric acid stones].
    Matouschek E; Böwering R
    Klin Wochenschr; 1968 Sep; 46(18):1012-4. PubMed ID: 5697503
    [No Abstract]   [Full Text] [Related]  

  • 2. [Citric acid and uric acid secretion in urine of healthy patients and patients with uric acid stones before and after administration of a citric acid-citrate mixture].
    Matouschek E; Böwering R
    Klin Wochenschr; 1968 Sep; 46(18):1011-2. PubMed ID: 5697502
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the influence of conditions during urine collection on measurement of the major constituents of urinary calculi].
    Miyazaki Y; Ebisuno S; Kitagawa M; Morimoto S; Yasukawa S; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1985 Jun; 76(6):881-8. PubMed ID: 3934443
    [No Abstract]   [Full Text] [Related]  

  • 4. Easy-to-use equations for the estimation of urine relative saturation in the assessment of risk of recurrence in urinary stones formers.
    Plante G; Ouimet D; Robitaille R
    Clin Biochem; 2017 Sep; 50(13-14):794-796. PubMed ID: 28342804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Models for the formation of uric acid and urate stones.
    Berényi M
    Int Urol Nephrol; 1972; 4(2):199-204. PubMed ID: 4669643
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic treatment of uric acid calculi.
    Preminger GM
    Urol Clin North Am; 1987 May; 14(2):335-8. PubMed ID: 3576854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent versus continuous alkaline therapy for uric acid stones and ureteral stones of uncertain composition.
    Rodman JS
    Urology; 2002 Sep; 60(3):378-82. PubMed ID: 12350465
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of crystalluria in diabetic patients].
    Mbarki M; Jabrane J; Oussama A; Daudon M
    Prog Urol; 2005 Jun; 15(3):420-5; discussion 425-6. PubMed ID: 16097146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Hounsfield unit measurement and urine parameters to predict uric acid stones.
    Spettel S; Shah P; Sekhar K; Herr A; White MD
    Urology; 2013 Jul; 82(1):22-6. PubMed ID: 23688376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical changes of urine environment on propionhydroxamic acid therapy.
    Bruno M; Marangella M; Tricerri A; Martini C; Linari F
    Contrib Nephrol; 1987; 58():207-11. PubMed ID: 3691128
    [No Abstract]   [Full Text] [Related]  

  • 11. [Types for 1 849 patients with urinary calculi and patients' clinical characteristics].
    Xue J; Wang C; Jiang Z; Tan J; Liu D; Chen B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 43(8):852-857. PubMed ID: 30197312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calculation of titratable acidity from urinary stone risk factors.
    Kok DJ; Poindexter J; Pak CY
    Kidney Int; 1993 Jul; 44(1):120-6. PubMed ID: 8355452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary pH, ammonia and calcium excretion in renal uric acid stone patients.
    FRANK M; DE VRIES A; ATSMON A; KOCHWA S
    Isr Med J; 1960; 19():299-301. PubMed ID: 13701362
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary hydrogen ion excretion in patients with uric acid calculi.
    Wrong O
    Proc R Soc Med; 1966 Apr; 59(4):313-5. PubMed ID: 5937679
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of pH, of titrable acidity, and urinary buffer system in oxalate lithiasis, in gout and urate lithiasis].
    Thomas J; Thomas E; Rabussier H; Desgrez P
    Rein Foie; 1968; 11():109-70. PubMed ID: 5741315
    [No Abstract]   [Full Text] [Related]  

  • 16. [Allopurinol induced electrolyte and metabolism changes in the urine of patients with kidney stones].
    Schwille PO; Jügelt U; Sigel A
    Urologe A; 1972 Jul; 11(4):185-9. PubMed ID: 5071601
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissolution of uric acid-urate stones and prophylaxis of recurrency with Magurlit.
    Baán L; Jancsó T; Ficsor E; Makáry G; Walter G
    Ther Hung; 1983; 31(3):127-8. PubMed ID: 6571187
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
    Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
    Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in some serum and urine laboratory indices in idiopathic uric acid lithiasis after administration of Eisenberg solution.
    Krawczyński J; Zulawnik W; Drewnowska I
    Pol Med J; 1967; 6(3):539-46. PubMed ID: 6038075
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis.
    Pak CY; Poindexter JR; Peterson RD; Koska J; Sakhaee K
    Urology; 2002 Nov; 60(5):789-94. PubMed ID: 12429297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.